Garlic for Cardiovascular Disease: Prevention or Treatment?

被引:34
|
作者
Alali, Feras Q. [1 ]
El-Elimatb, Tamam [2 ]
Khalid, Lila [2 ]
Hudaib, Reema [2 ]
Al-Shehabi, Tuqa Saleh [3 ]
Eid, Ali H. [4 ]
机构
[1] Qatar Univ, Fac Pharm, POB 2713, Doha, Qatar
[2] Jordan Univ Sci & Technol, Fac Pharm, Dept Med Chem & Pharmacognosy, Irbid 22110, Jordan
[3] Qatar Univ, Dept Hlth Sci, Doha, Qatar
[4] Amer Univ Beirut, Fac Med, Dept Pharmacol & Toxicol, POB 11-0236, Beirut, Lebanon
关键词
Cardiovascular disease; atherosclerosis; hypertension; thrombosis; hyperlipidemia; garlic; Allium sativum; herbal medicine; DIASTOLIC BLOOD-PRESSURE; HYDROGEN-SULFIDE; ALLIUM-SATIVUM; S-ALLYLCYSTEINE; DOUBLE-BLIND; DRUG-INTERACTIONS; POWDER TABLETS; SERUM-LIPIDS; RISK-FACTORS; IN-VITRO;
D O I
10.2174/1381612822666161010124530
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cardiovascular disease (CVD) is the leading cause of global mortality with a substantial economic impact. The annual deaths are expected to increase in the next decade. An array of dietary supplements is being used by people worldwide to ameliorate cardiovascular risk factors. Garlic (Allium sativum L.), a top-selling herbal dietary supplement, is renowned for its wide range beneficial effects, particularly in the treatment and prevention of CVD. This review aims to present a thorough discussion of the available evidence-based data which support the use of garlic in the treatment or prevention of cardiovascular diseases, including atherosclerosis, hypertension, and hyperlipidemia. The molecular mechanisms underlying these effects are dissected as well. This review supports the notion that garlic has the potential to treat mild hypertension, to decrease hypercholes-terolemia, and to prevent atherosclerosis. More clinical studies are essential to unequivocally understand the mechanisms underlying treatment or prevention of these cardiovascular conditions.
引用
收藏
页码:1028 / 1041
页数:14
相关论文
共 50 条
  • [1] Soy, garlic, and ginkgo biloba: Their potential role in cardiovascular disease prevention and treatment
    Christopher D. Gardner
    Mark Messina
    Larry D. Lawson
    John W. Farquhar
    Current Atherosclerosis Reports, 2003, 5 (6) : 468 - 475
  • [2] Cardiovascular disease prevention and treatment
    von Schacky, Clemens
    PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2009, 81 (2-3): : 193 - 198
  • [3] Aspirin in the treatment and prevention of cardiovascular disease
    Gaziano, JM
    Skerrett, PJ
    Buring, JE
    HAEMOSTASIS, 2000, 30 : 1 - 13
  • [4] Aspirin in the treatment and prevention of cardiovascular disease
    Hennekens, CH
    ANNUAL REVIEW OF PUBLIC HEALTH, 1997, 18 : 37 - 49
  • [5] Magnesium for the prevention and treatment of cardiovascular disease
    DiNicolantonio, James J.
    Liu, Jing
    O'Keefe, James H.
    OPEN HEART, 2018, 5 (02):
  • [6] Worksite treatment for cardiovascular disease prevention
    Michael H. Alderman
    Current Hypertension Reports, 2007, 9 : 342 - 343
  • [7] Aspirin for Prevention and Treatment of Cardiovascular Disease
    Mehta, Shamir R.
    ANNALS OF INTERNAL MEDICINE, 2009, 150 (06) : 414 - 416
  • [8] Advances in the prevention and treatment of cardiovascular disease
    Weisfeldt, Myron L.
    Zieman, Susan J.
    HEALTH AFFAIRS, 2007, 26 (01) : 25 - 37
  • [9] Worksite treatment for cardiovascular disease prevention
    Alderman, Micbael H.
    CURRENT HYPERTENSION REPORTS, 2007, 9 (05) : 342 - 343
  • [10] Ramipril for the prevention and treatment of cardiovascular disease
    Vuong, AD
    Annis, LG
    ANNALS OF PHARMACOTHERAPY, 2003, 37 (03) : 412 - 419